These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8199046)

  • 1. Serum macrophage colony-stimulating factor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early-stage B-CLL.
    Jewell AP; Yong KL; Worman CP; Tsakona CP; Giles FJ; Goldstone AH
    Br J Haematol; 1994 Feb; 86(2):441-3. PubMed ID: 8199046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable response of early stage B CLL patients to treatment with IFN-alpha 2.
    Ziegler-Heitbrock HW; Schlag R; Flieger D; Thiel E
    Blood; 1989 May; 73(6):1426-30. PubMed ID: 2713486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemia.
    McSweeney EN; Giles FJ; Worman CP; Jewel AP; Tsakona CP; Hoffbrand AV; Mehta AB; Newland AC; Cawley JC; Galvani D
    Br J Haematol; 1993 Sep; 85(1):77-83. PubMed ID: 8251412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy.
    Jewell AP; Worman CP; Giles FJ; Goldstone AH
    Leuk Lymphoma; 1997 Jan; 24(3-4):327-33. PubMed ID: 9156662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alfa-2b therapy in untreated early stage, B-chronic lymphocytic leukaemia patients: one-year follow-up.
    Boussiotis VA; Pangalis GA
    Br J Haematol; 1991 Oct; 79 Suppl 1():30-3. PubMed ID: 1931705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of 2',5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemia.
    Musolino C; Grosso P; Alonci A; Allegra A; Orlando A; Cincotta M; Buda G; Squadrito G
    Am J Hematol; 1993 May; 43(1):1-4. PubMed ID: 8317456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage colony stimulating factor involvement in uremic patients.
    Le Meur Y; Fixe P; Aldigier JC; Leroux-Robert C; Praloran V
    Kidney Int; 1996 Sep; 50(3):1007-12. PubMed ID: 8872977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation and activation antigens on blood mononuclear cells in lymphocytic leukemia before and during IFN-alpha 2B therapy.
    Demeter J; Paloczi K; Bibok G; Lehoczky D
    Leukemia; 1992; 6 Suppl 3():41S-45S. PubMed ID: 1602826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose "natural" alpha-interferon in B-cell derived chronic lymphocytic leukemia.
    Pozzato G; Franzin F; Moretti M; Tulissi P; Pecorari P; Melato M; Zacchi T; Evangelisti P; Campanacci L
    Haematologica; 1992; 77(5):413-7. PubMed ID: 1483591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment strategies for early-stage chronic lymphocytic leukemia: can interferon-inducible MxA protein and tumor necrosis factor play a role as predictive markers for response to interferon therapy?
    Bezares F; Kohan S; Sacerdote de Lustig E; Farías E; Murro H; Horisberger MA
    J Interferon Cytokine Res; 1996 Jul; 16(7):501-5. PubMed ID: 8836914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-alpha 2b (IFN alpha) for early-phase chronic lymphocytic leukaemia with high risk for disease progression: results of a randomized multicentre study.
    Langenmayer I; Nerl C; Knauf W; Dempster S; Hallek M; Adorf D; Dietzfelbinger H; Busch R; Ziegler-Heitbrock HW; Thiel E; Emmerich B
    Br J Haematol; 1996 Aug; 94(2):362-9. PubMed ID: 8759897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of early stage B-cell chronic lymphocytic leukemia with alpha-interferon. Gruppo per lo Studio e la Cura delle Gammapatie Monoclonali.
    Haematologica; 1991; 76(4):298-304. PubMed ID: 1794737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interferon-alpha on peripheral neutrophil counts and serum granulocyte colony-stimulating factor levels in chronic hepatitis C patients.
    Fukuda A; Kobayashi H; Teramura K; Yoshimoto S; Ohsawa N
    Cytokines Cell Mol Ther; 2000 Sep; 6(3):149-54. PubMed ID: 11140884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b.
    Fuchs D; Norkrans G; Wejstal R; Reibnegger G; Weiss G; Weiland O; Schvarcz R; Fryden A; Wachter H
    Eur J Med; 1992; 1(4):196-200. PubMed ID: 1341444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 is a survival prognostic factor in renal cell carcinoma.
    Thiounn N; Pages F; Flam T; Tartour E; Mosseri V; Zerbib M; Beuzeboc P; Deneux L; Fridman WH; Debré B
    Immunol Lett; 1997 Jul; 58(2):121-4. PubMed ID: 9271323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo.
    Jewell AP; Worman CP; Lydyard PM; Yong KL; Giles FJ; Goldstone AH
    Br J Haematol; 1994 Oct; 88(2):268-74. PubMed ID: 7803269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
    Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
    Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes of neopterin in cerebrospinal fluid and serum in children with meningitis].
    Kawakami Y; Fukunaga Y; Hashimoto K
    No To Hattatsu; 1996 Jan; 28(1):23-9. PubMed ID: 8579853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon alfa-2B in chronic lymphatic leukemia of the B-cell type].
    Schlag R; Flieger D; Ziegler-Heitbrock HW; Hill W; Emmerich B; Thiel E
    Dtsch Med Wochenschr; 1990 Jul; 115(28-29):1088-95. PubMed ID: 2373039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient regression in lymphocyte count in B-cell chronic lymphocytic leukemia after viral infection.
    Shirono K; Ikebe M; Inada T; Tsuda H
    Acta Haematol; 1995; 93(1):46-9. PubMed ID: 7725850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.